Skip to content
Aromatase inhibitors (AI)

Anastrozol vs Letrozol vs Exemestane

The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.

What it is
Anastrozole (Arimidex)Prescription aromatase inhibitor for breast cancer that bodybuilders also use to lower estrogen; banned on the doping list.
Letrozole (Femara)Prescription aromatase inhibitor for breast cancer that lowers estrogen; bodybuilders also use it, and it is banned in competitive sport.
Exemestane (Aromasin)Prescription aromatase inhibitor for breast cancer that bodybuilders use to keep estrogen low; banned on the anti-doping list.
Mechanism
Anastrozole (Arimidex)Reversible aromatase inhibitor; lowers estrogen levels by over 90%
Letrozole (Femara)Non-steroidal aromatase inhibitor; estrogen can fall by up to about 99%
Exemestane (Aromasin)Steroidal "suicide" (irreversible covalent) CYP19 aromatase inhibitor – a single dose permanently inactivates a portion of the pool
Dosing (AAS)
Anastrozole (Arimidex)0.25-1 mg EOD-2x/week titrated by bloodwork (E2 trough 20-30 pg/mL LC-MS/MS)
Letrozole (Femara)0.25-1.25 mg EOD bloodwork-titrated; gyno reversal 2.5 mg/day × 14-21 days
Exemestane (Aromasin)12.5-25 mg EOD or 25 mg/day
Half-life
Anastrozole (Arimidex)~50 hours (single daily dose, steady-state day 7)
Letrozole (Femara)~42 hours
Exemestane (Aromasin)~27 h (parent), ~24-48 h active metabolite; pharmacodynamic effect 5-7 days
Onset
Anastrozole (Arimidex)E2 reduction measurable 24-48 h, full effect 5-7 days
Letrozole (Femara)E2 reduction measurable 24-48 h, plateau 4-6 days
Exemestane (Aromasin)E2 reduction measurable 12-24 h, full effect 3-5 days
Legal status
Anastrozole (Arimidex)FDA + EMA Rx, HU + PL approved, WADA S4.1 banned
Letrozole (Femara)FDA + EMA Rx, HU + PL approved, WADA S4.1 banned
Exemestane (Aromasin)FDA + EMA Rx, HU + PL approved, WADA S4.1 banned

Anastrozole, letrozole or exemestane: how do they differ?

All three block the same enzyme, the one that turns androgens into oestrogen, but not in the same way. Anastrozole and letrozole are non-steroidal and bind the enzyme reversibly; of the two, letrozole is described as the stronger blocker. Exemestane is steroidal and permanently switches off the enzyme molecules it attaches to: activity returns only as the body builds new enzyme. It is also the only one of the three whose entry notes a mildly androgenic breakdown product that lowers SHBG, so free testosterone rises measurably.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant